Tanapox virus disease
ICD-10 B08.71 is a billable code used to indicate a diagnosis of tanapox virus disease.
Tanapox virus disease is a rare viral infection caused by the Tanapox virus, which is part of the Poxviridae family. This disease is primarily found in certain regions of Africa, particularly in the vicinity of the Tanapox River in Kenya. The clinical presentation of Tanapox virus disease typically includes fever, malaise, and the development of skin lesions that may progress to vesicular or pustular forms. The lesions are often localized and can resemble those seen in other poxvirus infections. Diagnosis is primarily clinical, supported by serological tests or PCR for definitive identification of the virus. While the disease is generally self-limiting, it can lead to complications such as secondary bacterial infections of the skin lesions. Vaccination against other poxviruses, such as smallpox, may provide some cross-protection, but specific vaccines for Tanapox virus are not available. Understanding the epidemiology, clinical features, and potential complications of Tanapox virus disease is crucial for accurate diagnosis and management.
Detailed clinical notes including symptoms, laboratory results, and treatment plans.
Patients presenting with fever and skin lesions in endemic areas.
Ensure accurate documentation of travel history and exposure to endemic regions.
Photographic evidence of skin lesions and detailed descriptions of lesion morphology.
Patients with vesicular or pustular lesions that require differential diagnosis.
Document any secondary infections or complications arising from the lesions.
Used when laboratory confirmation of Tanapox virus is required.
Laboratory reports confirming the presence of Tanapox virus.
Infectious disease specialists should ensure accurate coding based on test results.
Common symptoms include fever, malaise, and the development of localized skin lesions that may progress to vesicular or pustular forms.
Currently, there is no specific vaccine for Tanapox virus; however, vaccination against smallpox may provide some cross-protection.